HR5162-119

What This Bill Does

The Colorectal Cancer Early Detection Act responds to rising colorectal cancer rates among younger adults. Its findings cite more than 141,000 new cases and 52,000 deaths in 2021, an estimated 154,270 new cases and 52,900 deaths in 2025, about one in five cases occurring in people age 54 or younger, and projected 90 percent growth in cases among ages 20 to 39 by 2030. The operative section authorizes the HHS Secretary, acting through CDC, to make competitive five-year renewable grants to states for colorectal cancer awareness, education, and early detection among young individuals under age 45. State plans must focus on high-risk young people, including those with family history, advanced adenomatous polyps, inflammatory bowel disease, Lynch syndrome, familial adenomatous polyposis, symptoms such as rectal bleeding or iron deficiency anemia, underserved and rural communities, American Indian, Alaska Native, African American, and type 2 diabetes populations. Allowable uses include early detection and diagnostic testing, genetic testing and counseling referrals, public education campaigns, health professional education, screening-quality monitoring, surveillance, family-history strategies, patient navigation, clinician decision support tools, evaluation, return of unspent funds, and state reports within five years.

Who Benefits and How

Young individuals at high risk for colorectal cancer benefit because states can fund early detection and diagnostic testing before age 45. Underserved rural patients benefit because grant plans must address rural and underserved areas rather than only general awareness. American Indian communities benefit because outreach priorities explicitly include populations with elevated colorectal cancer risk and access barriers. State health departments benefit from five-year renewable CDC grants for navigation, surveillance, education, and screening-quality systems.

Who Bears the Burden and How

CDC cancer prevention staff must run a competitive grant program, evaluate state plans, oversee renewals, and receive reports. State health departments must submit detailed plans, partner with hospitals and clinics, track grant activities, return unspent funds, and report within five years. Health professionals must absorb new education on early-onset colorectal cancer symptoms, genetic risks, family history, and diagnostic testing. Federal taxpayers bear the cost of grants for screening, diagnostics, patient navigation, and public education.

Key Provisions

• Creates competitive CDC grants for colorectal cancer awareness, education, and early detection among people under 45.
• Requires state plans to target high-risk groups including family history, IBD, inherited syndromes, symptoms, underserved areas, rural areas, and diabetes.
• Authorizes grant uses for diagnostic testing, genetic counseling referrals, patient navigation, clinician education, surveillance, and decision support.
• Requires five-year state reports and return of unspent grant funds within six months after the grant period.